BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 45 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,000 | -95.0% | 85,440 | -89.4% | 0.00% | – |
| Q2 2022 | $416,000 | -75.3% | 803,842 | -2.2% | 0.00% | – |
| Q1 2022 | $1,686,000 | -32.9% | 822,206 | +36.4% | 0.00% | – |
| Q4 2021 | $2,513,000 | +1202.1% | 602,692 | +2795.7% | 0.00% | – |
| Q3 2021 | $193,000 | -71.4% | 20,813 | -44.5% | 0.00% | – |
| Q2 2021 | $676,000 | – | 37,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |